Health care costs are a significant area of concern for everyone from patients to policymakers. Health services research evidence looks at different ways to address cost growth, encourage efficiency and quality, and provide for care via insurance, Medicare and Medicaid so that people receive the best care at the best value.
On June 1, 2022, the Health Resources & Services Administration (HRSA) released their "Blueprint for Change," in a supplement to AAP’s journal Pediatrics, outlining a strategic plan for improving the lives of CYSHCN. Four critical areas drive the “Blueprint for Change”: health equity, family and child well-being and quality of life, access to services, and financing of services.
This Data Note examines the extent of community health center involvement in systematic efforts to screen patients for the presence of social determinants of health and concludes that targeted grant support and Medicaid performance investments for the costs associated with social risk screening and reporting are needed for universal engagement by community health centers.
AcademyHealth CEO Dr. Simpson spoke with Dr. Joshua Liao on the podcast Health Equity Conversations which highlighted research priorities at the intersection of health equity and payment.
Research nominated as the best abstract for each theme from the 2022 Call for Abstracts explores topics related to patient and consumer needs, Medicaid access and coverage, COVID-19, and more.
Kate Goodrich, a theme lead for AcademyHealth’s Annual Research Meeting, highlights key research from the theme Payment and Delivery System Innovation that will be presented at the conference June 4-7.
There are numerous obstacles to consumer price shopping in health care and shifting patients’ behavior has been difficult. Recently, some insurers have used financial rewards to get beneficiaries to use lower-priced providers. In this ‘plain language summary,’ new research indicates the strategy may have some affect, although overall impacts of the program are modest.
Despite a need for financing reforms that better incentivize addressing patient whole health and wellness, the lack of clear standardization of social determinants of health screening tools, interoperable data collection systems, lack of robust health-related social services expenditure data, and financing uncertainties and insecurities present significant challenges for value-based payment arrangements, according to this analysis.
AcademyHealth and the National Pharmaceutical Council (NPC) consider the drivers of health spending in the U.S. through salons focused on challenging questions. Today’s post takes a closer look at how the macro health economy may evolve post-pandemic.
The annual Reinhardt Lecture honors a national leader who reflects the high standards of Professor Uwe Reinhardt. The 2021 lecturer was Dr. Sherry Glied, who honored Dr. Reinhardt’s trailblazing focus on price, rather than quantity, with a discussion of the role of price as a market signal. The following plain language summary offers highlights from the transcribed remarks, as delivered at the virtual 2021 Annual Research Meeting and published in the journal Health Services Research.
As the Centers for Medicare and Medicaid Services (CMS) moves to strengthen its price transparency efforts, a panel of experts recently discussed what advancements are necessary to provide consumers with accurate, useful information to make informed decisions about the cost and quality of care.
